PRECAMA: Molecular Subtypes of Premenopausal Breast Cancer in Latin American Women — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

PRECAMA: Molecular Subtypes of Premenopausal Breast Cancer in Latin American Women — Stella

Recruiting

Back to Breast Cancer Female trials

Trial locations(13 sites)

Brazil

Barretos Cancer Hospital, Barretos

Chile

INC, Santiago, Independencia

Hso-Crsco, Santiago, Peñalolén

FALP, Santiago, Providencia

Colombia

Grupo Infección y Cáncer. Universidad de Antioquia, Medellín, Antioquia

Key details

Sponsor

International Agency for Research on Cancer

Collaborators

University of Chile, Fundación Inciensa

Enrollment target

~3,000 participants

Started

October 2012

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

20 Years – 45 Years

Sex

Female only

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov